Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System.

Scientific data - 11 Nov 2022

Zhao Zheng, Zhang Ke-Nan, Sun Zhiyan, Yang Changlin, Wang Qiangwei, Li Guanzhang, Wang Zhiliang, Zeng Fan, Chai Ruichao, Qian Zenghui, Wang Zheng, Liu Yanwei, Ma Wenping, Wu Fan, Jiang Tao

Abstract excerpt

Diffuse gliomas (DGs) are the most common and lethal primary neoplasms in the central nervous system. The latest 2021 World Health Organization (WHO) Classification of Tumors of the Central Nervous System (CNS) was published in 2021, immensely changing the approach to diagnosis and decision making. As a part of the Chinese Glioma Genome Atlas (CGGA) project, our aim was to provide genomic profiling of gliomas in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Central Nervous System Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Glioma

Share to Mutation

Share to World Health Organization

Source

Open in PubMed Open full text

Identifiers

PMID: 36369198
DOI: 10.1038/s41597-022-01823-3
PMCID: PMC9652316

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System.PMID 36369198Read ↗

Molecular pathology and clinical implications of diffuse glioma.Semantic proximity Read ↗

2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review.Semantic proximity Read ↗

The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.Semantic proximity Read ↗

Classification of adult-type diffuse gliomas: Impact of the World Health Organization 2021 update.Semantic proximity Read ↗

Reclassification of TCGA Diffuse Glioma Profiles Linked to Transcriptomic, Epigenetic, Genomic and Clinical Data, According to the 2021 WHO CNS Tumor Classification.Semantic proximity Read ↗

Adult type diffuse gliomas in the new 2021 WHO Classification.Semantic proximity Read ↗

Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel.Semantic proximity Read ↗

The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas.Semantic proximity Read ↗

miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targetsSemantic proximity Read ↗

Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System.Semantic proximity Read ↗

The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 2-Summary of Imaging Findings on Pediatric-Type Diffuse High-Grade Gliomas, Pediatric-Type Diffuse Low-Grade Gliomas, and Circumscribed Astrocytic Gliomas.Semantic proximity Read ↗

Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology Report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.